Pure Extracts Begins Trading on the CSE

Pure Extracts开始在CSE交易

2020-11-06 02:31:10 CFN Media Group

本文共1494个字,阅读需4分钟

  Cannabis extracts are projected to become a $28.5 billion market by 2027, according to Grand View Market Research, representing a 16.6% compound annual growth rate. As consumers transition from cannabis flower to oils, tinctures, edibles, topicals and other products, cannabis extraction companies are playing a key role in the next stage of the industry’s expansion. There are hundreds of publicly traded cannabis companies, but few offer a pure play on extracts. On November 5, 2020, Pure Extracts Technologies Corp. (CSE: PULL) will become one of the few pure plays in the space following its listing on the Canadian Securities Exchange (CSE) under the ticker symbol “PULL”, providing easy access to the unique corner of the market. “Our trading debut on the CSE is another vote of confidence in our ability to effectively meet the needs of consumers focused on receiving cannabis, hemp and functional mushroom products,” said CEO Ben Nikolaevsky following the public listing announcement. Click here to receive and investor presentation and corporate updates Investing in Extracts Pure Extracts aims to become a leader in the extraction of cannabinoids. With a 10,000 sq. ft. EU-GMP compliant facility, the Company is uniquely positioned to process raw cannabis and hemp biomass into high-margin extracts. The Company’s white label services can also package them into vapes, edibles, soft gels, beverages and a number of different oil-based products. “There is currently a tremendous consumer demand for natural health products with the ability to immediately enhance our quality of life,” said CEO Ben Nikolaevsky. “With Health Canada officially granting Pure Extracts a Standard Processing License under the Cannabis Act, this has put us on a path to deliver full-spectrum oil (FSO) products by the end of Q4 2020.” In addition to tolling and white label sales the Company is developing its own line of proprietary products that it plans to sell into the Canadian marketplace—and eventually beyond. These proprietary products already include a line of premium vape products under the Pure Pulls brand, which will be available for sale in licenced Canadian dispensaries early next year. Pure Extracts also plans on expanding into the emerging functional mushroom wellness space, a market that has experienced tremendous growth over the past few years. With a growing body of research supporting the use of mushroom extracts in the treatment of mental health disorders, regulators have opened the door for researchers to pursue clinical studies. As with cannabis and cannabidiol (CBD), Pure Extracts aims to position itself as a leading extractor in the space, capable of creating a wide range of products from mushroom-based raw materials. The Company could also provide raw materials for researchers interested in the space that may not have the means to grow and extract their own product. The move could create new opportunities to profit outside of the cannabis industry while sticking to its core competency of extracting high-value products from plant-based raw materials. For investors, it represents an attractive, high-growth horizontal market that could have even more potential than the cannabis industry. Click here to receive and investor presentation and corporate updates Investors interested in cannabinoid extraction may want to take a closer look at Pure Extracts Technologies Corp. (CSE: PULL) following its listing on the Canadian Securities Exchange. With its high margin recurring revenue business model, the Company is well positioned to scale up in the near-term while adding blue-sky potential in the form of proprietary branded products. For more information, visit the company’s website or download their investor presentation. The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/ This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
根据Grand View market Research的数据,预计到2027年,大麻提取物市场规模将达到285亿美元,复合年增长率为16.6%。随着消费者从大麻花转向大麻油,酊剂,食用品,局部用药和其他产品,大麻提取公司在该行业下一阶段的扩张中发挥着关键作用。 有数百家公开交易的大麻公司,但很少有人提供纯粹的提取物。2020年11月5号,Pure Extracts Technologies Corp.(CSE:PULL)在加拿大证券交易所(CSE)上市,股票代码为“PULL”,将成为该领域为数不多的几家Pure公司之一,为进入该市场的独特角落提供便利。 首席执行官Ben Nikolaevsky在宣布上市后说:“我们在CSE的首次交易是对我们的能力投下的又一张信任票,我们有能力有效地满足那些专注于接收大麻,大麻和功能性蘑菇产品的消费者的需求。 点击这里接收投资者介绍和公司更新 投资于提取物 Pure Extracts的目标是成为大麻素提取领域的领导者。有一万平方米。FT.符合EU-GMP标准的设施,该公司处于独特的位置,可以将生大麻和大麻生物质加工成高利润的提取物。该公司的白标服务也可以包装成蒸汽,可食用,软凝胶,饮料和一些不同的油基产品。 首席执行官Ben Nikolaevsky说:“目前消费者对能够立即提高我们生活质量的天然健康产品有着巨大的需求。”“随着加拿大卫生部根据《大麻法》正式授予纯提取物标准加工许可证,这使我们走上了在2020年第四季度末交付全谱油(FSO)产品的道路。” 除了收费和白标签销售外,该公司正在开发自己的专有产品线,计划将这些产品销往加拿大市场,并最终销往更远的地区。这些专利产品已经包括Pure Pulls品牌下的一系列高级vape产品,这些产品将于明年初在加拿大获得许可的药房销售。 Pure Extracts还计划扩展到新兴的功能性蘑菇保健领域,这个市场在过去几年里经历了巨大的增长。随着越来越多的研究支持蘑菇提取物用于治疗精神疾病,监管机构已经为研究人员打开了进行临床研究的大门。 与大麻和大麻二醇(CBD)一样,Pure Extracts的目标是将自己定位为该领域领先的提取商,能够从蘑菇原料中创造出广泛的产品。该公司还可以为对太空感兴趣的研究人员提供原材料,这些研究人员可能没有办法种植和提取他们自己的产品。 此举可创造新的机会,在大麻业之外获利,同时坚持其从植物原料中提取高价值产品的核心能力。对投资者来说,这是一个有吸引力的,高增长的横向市场,可能比大麻业更有潜力。 点击这里接收投资者介绍和公司更新 对大麻素提取感兴趣的投资者可能想仔细看看Pure Extracts Technologies Corp.(CSE:PULL),该公司在加拿大证券交易所上市。凭借其高利润率的经常性收入业务模式,该公司处于有利地位,可在短期内扩大规模,同时以专有品牌产品的形式增加蓝天潜力。 欲了解更多信息,请访问公司网站或下载他们的投资者演示文稿。 以上文章为赞助内容。Cannabisfn.com和CFN Media已被雇用来提高人们的认识。请按以下链接查看我们对薪酬的全面披露:http://www.cannabisfn.com/legal-disclaimer/ 本文由CFN Enterprises Inc.(OTCQB:CNFN)发布,CFN Media的所有者和运营商,CFN Media是行业领先的代理机构和数字金融媒体网络,致力于新兴的CBD和合法大麻行业。请致电+1(833)420-CNFN了解更多信息。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文